DR, DQ, and you: MHC alleles and autoimmunity
Open Access
- 1 April 2001
- journal article
- editorial
- Published by American Society for Clinical Investigation in Journal of Clinical Investigation
- Vol. 107 (7) , 795-796
- https://doi.org/10.1172/jci12634
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- The regulatory role of DR4 in a spontaneous diabetes DQ8 transgenic modelJournal of Clinical Investigation, 2001
- Co-expression of HLA DR3 and DQ8 results in the development of spontaneous insulitis and loss of tolerance to GAD65 in transgenic mice.Diabetes, 2000
- Complementation between specific HLA-DR and HLA-DQ genes in transgenic mice determines susceptibility to experimental autoimmune encephalomyelitisHuman Immunology, 2000
- In Vivo Evidence for the Contribution of Human Histocompatibility Leukocyte Antigen (Hla)-Dq Molecules to the Development of DiabetesThe Journal of Experimental Medicine, 2000
- HLA class II transgenic mice: models of the human CD4+ T‐cell immune responseImmunological Reviews, 1999
- The role of MHC class II molecules in susceptibility and resistance to autoimmunityCurrent Opinion in Immunology, 1998
- Identification of naturally processed T cell epitopes from glutamic acid decarboxylase presented in the context of HLA-DR alleles by T lymphocytes of recent onset IDDM patients.Journal of Clinical Investigation, 1997
- HLA-Encoded Genetic Predisposition in IDDM: DR4 Subtypes May Be Associated With Different Degrees of ProtectionDiabetes, 1997
- Characterization of PPD‐Specific T‐Cell Lines Generated in Type I (Insulin‐Dependent) Diabetic and Healthy IndividualsScandinavian Journal of Immunology, 1989
- HLA-DQβ gene contributes to susceptibility and resistance to insulin-dependent diabetes mellitusNature, 1987